Administered by URVentures, the Technology Development Fund makes awards of up to $100K for researchers to develop a technology to a more commercial endpoint.
The Drug Development Pilot Award supports projects in drug development research that result in technology development, extramural funding, and commercialization.
The Pilot Studies Program provides seed funding for highly innovative translational and clinical research that addresses translational research questions, and provides insights generalizable to other projects.
The Center for Emerging & Innovative Sciences administers two awards: The Collaborative Innovative Research (CIR) award and the Short Term Applied Research (STAR) award. CIR funding is up to $30K and requires a minimum 2:1 company match, and STAR funding is up to $5K and requires a 1:1 match.
The University Research Awards (URA) provide seed grants for high promising, high-risk projects.
The Empire Discovery Institute (EDI) is a drug discovery partnership between the University of Rochester, the University of Buffalo, and Roswell Park Comprehensive Cancer Center. EDI is designed to help overcome key challenges typically faced by life science researchers in academia – lack of external funding to continue research efforts and lack of pharmaceutical industry expertise to advance these programs to fruition. Learn more about the EDI Medicines Discovery Award Program.
The National Science Foundation (NSF) I-Corps Site program provides entrepreneurial training and modest grant funding to University students, faculty, staff and alumni interested in commercializing a technical (STEM) business idea. Program participants can apply for up to $3,000 in grant funding to conduct customer discovery, market research or purchase supplies to create a prototype.
The Valerie and Frank Furth Fund provides $12,500 awards to help foster the development of promising scientists in the natural and biological sciences.